Figure 2.
Kaplan-Meier estimates of PFS among chemotherapy as first-line and second-line AGC patients treated with paclitaxel, cisplatin and fluorouracil
Kaplan-Meier estimates of PFS among chemotherapy as first-line and second-line AGC patients treated with paclitaxel, cisplatin and fluorouracil